BELGIUM – UCB has completed the previously announced acquisition of international biopharmaceutical firm Zogenix for up to US$1.9 billion (€1.7 billion). UCB signed a definitive agreement in January to acquire…
Read MoreUCB completes acquisition of Zogenix for US$1.9bn
